FSD Pharma Announces Acquisition To Expand In Newfoundland

Strategic investment of $40 million to bring economic benefits to province of Newfoundland

CANADA: FSD Pharma announced a binding agreement to purchase 51% of Atlantic Island Cannabis (to be renamed FSD Atlantic Pharma Inc.) effective July 4, 2018. The agreement involves a strategic investment of $40 million to drive production and sales of legal cannabis in the province of Newfoundland. In the first phase of the project, an indoor high quality 45,000 Read the full article…